Clinical Trial

Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

Study acronym: UNIQUE
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2023 (before its estimated October 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II study to investigate the feasibility of Ultra-hypofractionated radiotherapy with or without simultaneous integrated boost for low risk breast cancer patients who have received breast conservative surgery of mastectomy.
Trial Details
NCT Number NCT05762900
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Breast Cancer, Radiotherapy Side Effect
Enrollment 65 participants
Start Date 2022-10-25
Primary Completion 2025-10-25 (estimated)
Study Completion 2030-10-25 (estimated)
Updated on ClinicalTrials.gov 2023-03-10